Incoming and outgoing links Prurigo chronische
Back to articleIncoming links
- Aprepitant
- Kollagenose reaktive perforierende
- CXCL2
- Pruritus diabeticorum
- Dupilumab
- Epidermolysis bullosa dystrophica pruriginosa rezessiv
- Gabapentin
- Hodgkin-Lymphom, Hautveränderungen
- Hyde, James Nevin
- Lichen planus verrucosus
- Interleukin-31
- Hyperkeratosis follicularis et parafollicularis in cutem penetrans
- Lichen amyloidosus
- Lichen corneus disseminatus
- Lichen obtusus corneus
- Lichénifications circonscrits nodulaires chroniques
- Lymphomatoide Papulose
- Lichenificatio maculopapulosa
- Monoklonale Antikörper
- Naltrexon
- Nemolizumab
- Neurodermitis nodosa
- Lichenificatio nodularis
- Papulae obtusae
- Prurigo, noduläre
- Prurigo nodularis
- Prurigo simplex subacuta
- Thalidomid
- Tofacitinib
- Urticaria perstans chronica papulosa
- Urticaria perstans verrucosa
- Vixarelimab
Outgoing links
- Abrocitinib
- Amitriptylin
- Antihistaminika, systemische
- Aprepitant
- Atopische Dermatitis (Übersicht)
- Baricitinib
- Ciclosporin A
- Clemastin
- Kryochirurgie
- CXCL2
- Dimetinden
- Dupilumab
- Farbstoff-Laser
- ECP
- Gabapentin
- Glukokortikosteroide
- Gluten
- Hydroxyzin
- Lichen planus verrucosus
- IMP3
- Interleukin-31
- Intraepidermale Nervenfaserdichte
- JAK-STAT-Signalweg
- Januskinase 2
- JAK-Inhibitoren
- Keratoakanthome multiple eruptive
- Köbner-Phänomen
- Laser
- Mastzelle
- Matrix-Metalloproteinasen
- Nemolizumab
- Nervenwachstumsfaktor
- Off-Label-Use
- Oncostatin-M-Rezeptor
- Pemphigoid bullöses (Übersicht)
- Pregabalin
- Prostaglandine
- Prurigo simplex subacuta
- PUVA-Therapie
- Rheumatoide Arthritis Hauterkrankungen
- Small Fiber Neuropathie
- Thalidomid
- Tofacitinib
- Triamcinolon
- Tryptase
- Upadacitinib
- Vixarelimab